CIK 0000898437 · Accelerated filer
Anika Therapeutics, Inc.
Sign in to watch- Ticker
- ANIK
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043145961
- Phone
- (781) 457-9000
- Business address
- 32 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ANIKA THERAPEUTICS INC, ANIKA RESEARCH INC
- 4 Open-market sale CEO and Director sold 63,799 shares at $50.79 ($3,240,351)
- 4 Grant or award President acquired 14,506 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Results of operations
- 8-K Event Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market sale President, CEO, Director sold 14,201 shares at an average $50.03 ($710,544)
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market sale Director sold 10,725 shares at an average $47.39 ($508,274)
- 8-K/A Event Auditor change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Auditor change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 24 of 55 · 1,098 filings